Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Allergy and Clinical Immunology|December 11, 2012
Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitisEli O Meltzer, Michael Schatz, Robert Nathan, et al.
Allergy and Asthma Proceedings|March 1, 2011
Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitisPhil Lieberman, Eli O Meltzer, Craig F LaForce, et al.
Allergy and Asthma Proceedings|May 25, 2021
Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergiesTonya Winders, Lawrence DuBuske, Don A Bukstein, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 6, 2011
Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combinationCraig LaForce, Cindy Weinstein, Robert A Nathan, et al.
International Journal of Technology Assessment in Health Care|December 7, 2016
IMPLICATION OF ALTERNATIVE MINIMAL CLINICALLY IMPORTANT DIFFERENCE THRESHOLD ESTIMATION METHODS ON TECHNOLOGY ASSESSMENTDiana Brixner, Eli O Meltzer, Kellie Morland, et al.
Allergy and Asthma Proceedings|December 25, 2009
Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitisWilliam E Berger, Paul H Ratner, Thomas B Casale, et al.
Mayo Clinic Proceedings|April 9, 2002
Use of intranasal cromolyn sodium for allergic rhinitisPaul H Ratner, Paul M Ehrlich, Stanley M Fineman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 20, 2007
Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitisEli O Meltzer, Sudeesha Kunjibettu, Nancy Hall, et al.
Allergy and Asthma Proceedings|January 19, 2008
Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitisCarol J Fairchild, Eli O Meltzer, Peter S Roland, et al.
Allergy and Asthma Proceedings|September 4, 2013
An algorithm for the management of allergic conjunctivitisLeonard Bielory, Eli O Meltzer, Kelly K Nichols, et al.
Pageof 15